chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Extreme fatigue that lasted 2 days. The first day I slept 19 hours. The second I slept 14. The following 3 days I was groggy, but it was manageable.
Breathing symptoms linger; Tested positive for covid.19; Terrible symptoms; Got covid-19 month after getting both doses of the vaccine back in Feb2021 and Mar2021; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Breathing symptoms linger), COVID-19 (Tested positive for covid.19), VACCINATION COMPLICATION (Terrible symptoms) and DRUG INEFFECTIVE (Got covid-19 month after getting both doses of the vaccine back in Feb2021 and Mar2021) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In April 2021, the patient experienced DRUG INEFFECTIVE (Got covid-19 month after getting both doses of the vaccine back in Feb2021 and Mar2021). On an unknown date, the patient experienced DYSPNOEA (Breathing symptoms linger), COVID-19 (Tested positive for covid.19) and VACCINATION COMPLICATION (Terrible symptoms). At the time of the report, DYSPNOEA (Breathing symptoms linger) had not resolved, COVID-19 (Tested positive for covid.19) and DRUG INEFFECTIVE (Got covid-19 month after getting both doses of the vaccine back in Feb2021 and Mar2021) outcome was unknown and VACCINATION COMPLICATION (Terrible symptoms) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Positive.         Relevant concomitant medications were not provided.  Treatment medication was not provided. For mRNA-1273 (Moderna COVID-19 Vaccine) (unknown), the reporter did not provide any causality assessments. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (unknown) was not applicable.  Company Comment: Based on biological implausibility the event of COVID-19 infection causality is assessed as not applicable in relation to mRNA-1273.  This is also a case of Drug ineffective (Lack of drug effect) assuming the patient had 2 doses of Moderna vaccine in the correct interval (25-35 days). Based on the current available information and temporal association between the use of the product and the tentative start date of the occurrence of the events, Dyspnoea (Breathing symptoms linger), Vaccination complication (Terrible symptoms), a causal relationship cannot be excluded.; Sender's Comments: Based on biological implausibility the event of COVID-19 infection causality is assessed as not applicable in relation to mRNA-1273.  This is also a case of Drug ineffective (Lack of drug effect) assuming the patient had 2 doses of Moderna vaccine in the correct interval (25-35 days). Based on the current available information and temporal association between the use of the product and the tentative start date of the occurrence of the events, Dyspnoea (Breathing symptoms linger), Vaccination complication (Terrible symptoms), a causal relationship cannot be excluded.
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose 01/10/21Moderna lot#012L20A 2nd dose: 02/0721, Moderna lot#012M20A Diagnosed covid positive:07/29/21 Symptom onset:07/27/21 Exposure:Home exposure Symptoms:cough, runny nose, head ache
67/f pt with chronic HBV,  HTN, pre-DM, HLD, cervical spinal stenosis, vaccinated with Moderna 2/16 & 3/18, no booster, exposure to family member who was covid +ve, recent diagnosis of  with COVID-19 disease on 12/11 outside hospital, who p/t ED on 12/15 with covid PNEUMONIA  with severe sepsis (elevated lactate, tachypnea). Had acute hypoxic respiratory failure noted on home oximetry.    Severe sepsis due to COVID-19 infection with acute hypoxic respiratory failure:  Symptom onset on 12/8. COVID positive on 12/11. Needs isolation 20 days from onset of symptoms per ID. -Decadron 6mg daily, 3 more days left as of today. Discharged on PO decadron.  Completed 5 days of Remdesivir, completed on 12/19. -Pepcid given for GI prophylaxis - Lovenox 40mg SQ given daily for dvt ppx   Passed road test on 12/18. DC held on 12/18 d/t dizziness which is chronic (takes PRN meclizine), on 12/19 reported coughing and saying she could not eat, even though it's documented that she was eating 100%. Had abdominal pain from coughing, tylenol increased to 1 G TID, lactulose added. Updated daughter that covid will take a long time and she has no indication for hospital stay. Road test results from 12/18- "ambulate 35 feet roomair, pre; 96% during 94% resting 96%  no sob, tolerate well , ambulate again over 100feet  94-96 % pre, during, post,1014 pt. Having dizziness bp 122/54 hr60 sats 96% given ,notice  Intense coughing without face mask even enough mask at bedside, re -guide to patient"   HTN: Continued Amlodipine   Cervical spinal stenosis: Continue Gabapentin and Baclofen daily which she takes.    Insomnia: Given Melatonin 3 mg and Trazodone 25 mg at nights.    Discharge Disposition:  Home health.    Condition on Discharge: stable   Medications, instructions, follow up information: See patient Discharge Instructions/AVS.   Subjective: Ongoing cough with associated urine incontinence. Was told that recovery will be slow but her symptoms should improve.
Still having a sore arm/When she move it, it hurts like hell/muscle is hurting really bad/it hurts to move her arm; Around where she got the shot it hurts really bad when she does certain things/hurts to move/hurting started pretty much right after vaccination; The person put it in the wrong spot; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Still having a sore arm/When she move it, it hurts like hell/muscle is hurting really bad/it hurts to move her arm), VACCINATION SITE PAIN (Around where she got the shot it hurts really bad when she does certain things/hurts to move/hurting started pretty much right after vaccination) and PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (The person put it in the wrong spot) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013F21A and 025A21A) for COVID-19 vaccination.     Concurrent medical conditions included Thyroid disorder NOS. Concomitant products included LEVOTHYROXINE SODIUM (LEVOTHYROXINE [LEVOTHYROXINE SODIUM]) for Thyroid disorder NOS.   On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Nov-2021, the patient experienced VACCINATION SITE PAIN (Around where she got the shot it hurts really bad when she does certain things/hurts to move/hurting started pretty much right after vaccination) and PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (The person put it in the wrong spot). On 07-Feb-2022, the patient experienced MYALGIA (Still having a sore arm/When she move it, it hurts like hell/muscle is hurting really bad/it hurts to move her arm). The patient was treated with ACETYLSALICYLIC ACID, ASCORBIC ACID (ASPIRIN [ACETYLSALICYLIC ACID;ASCORBIC ACID]) ongoing since an unknown date for Adverse event, at an unspecified dose and frequency. On 27-Nov-2021, PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (The person put it in the wrong spot) had resolved. At the time of the report, MYALGIA (Still having a sore arm/When she move it, it hurts like hell/muscle is hurting really bad/it hurts to move her arm) and VACCINATION SITE PAIN (Around where she got the shot it hurts really bad when she does certain things/hurts to move/hurting started pretty much right after vaccination) had not resolved.            The patient states the hurting started pretty much right after the vaccination, so it's been two months now. The patient states she never had a history of COVID positive. The patient has no known allergies and no other health conditions.   This case was linked to MOD-2022-475010, MOD-2022-475042 (Patient Link).
Itchy, red rash under arms, on back of neck, all over arms, chest, lower back, wrists; would not clear with methylprednisone 6-day/21 pill dose.  This lasted for two months. The rash still appears intermittently.  Asthma-must now use rescue inhaler at least five times per day when prior to both doses, used on average once per month.  I never used a nebulizer before but now must use at least 3 times per week.  My immune system has been adversely affected.  I have a persistent cough, shortness of breath, a feeling that my throat is closing.  I get sick with a cold and can't seem to shake it or it relapses.  Immediately following first dose-lightheadedness, shortness of breath, feeling of blacking out  After first dose-no appetite for three days-did not eat  Second dose, 3 hours later-loss of appetite, did not eat or drink for 3 days  Second dose-2 weeks later right knee gave out at top of stairs  Second dose, exactly 3 weeks later-sudden onset of lightheadedness, heart palpitations,  unable to walk because situational awareness was lost; teenage daughter had to help me upstairs so I wouldn't fall. I  sat on one spot for three hours, afraid to move.  I was overall much healthier prior to having received the vaccine. It might have damaged my immune system permanently.
Chronic headaches daily since the vaccine. I had a headache for days after the first vaccine shot on December 30, 2020, but after the second shot I have daily headaches. The only relief I have is while I'm sleeping and early morning. Advil/Tylenol/Excedrin only take the edge off, but do not make it go away. They are not migraines, nor are they debilitating, but they are distracting and uncomfortable and they are across the top of my head (ear to ear) and on the crown of my head.
no adverse event; The patient was supposed to return in October 2019 to receive his 3rd Gardasil 9, but it is now December; This spontaneous report was received from a pharmacist concerning a male patient of unknown age. No information was provided regarding the patient's pertinent medical history, concomitant medications or drug reactions/allergies.  On 16-APR-2019, the patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) for prophylaxis (dosage schedule, anatomical location, route of administration, lot number and expiration date were not reported).  On 18-JUN-2019, the patient was administered the second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) for prophylaxis (dosage schedule, anatomical location, route of administration, lot number and expiration date were not reported).     In October 2019, the patient was supposed to return to receive his third hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) dose.  In December 2019, the patient was requesting his third dose (inappropriate schedule of product administration).     No additional adverse event reported.
No additional AE reported; improperly stored administered VARIVAX; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.  On 12-FEB-2021, the patient was vaccinated with improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) dose 0.5 milliliter, lot # T024283; expiration date: 15-JUL-2022 (route of administration and anatomical location were not provided) for prophylaxis. The temperature was between 6 and 14 Fahrenheit degrees for 87 hours. There were no previous temperature excursions. The event was reported due to digital data logger. No additional adverse event (AE) was reported.
the day after first injection I started to get a low grade headache and mild nausea that I still have every day.
AFTER GIVING PATIENT VACCINE, SHE FELT LIGHTHEADED, AND STATED HER SUGAR WAS LOW. GAVE PATIENT A BOTTLE OF COKE, AND GLUCOSE TABLETS, PATIENT WANTED TO LAY DOWN AFTER ABOUT 10 MINUTES, THEN STARTING HAVING A SEIZURE. EMS ARRIVED AND SHE WAS AWAKE AND COHERENT AS THEY TOOK HER OUT
reported by mom to have lt arm swelling, redness, w/pale circle around inj site & small bumps/blisters down lt arm, face & rt leg; no fever; instructed to give APAP & call PMD; TC fr mom reporting sx approx 24hrs p/inj
Patient reported getting first Moderna Shot prior to incarceration. She was given a shot of Moderna. When recording her shot it was found to be her first dose was Pfizer.
Early menstrual cycle. Prolonged spotting prior to and after menstrual cycle.  Duration has been 3 menstrual cycle. Issue has not stopped.
patient received only the liquid portion of Menveo 2 vial; patient received only the liquid portion of Menveo 2 vial; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 17-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA9, expiry date 31-OCT-2024) for prophylaxis.   On 23-OCT-2023, the patient received Menveo. On 23-OCT-2023, an unknown time after receiving Menveo, the patient experienced inappropriate preparation of medication (Verbatim: patient received only the liquid portion of Menveo 2 vial) and inappropriate dose of vaccine administered (Verbatim: patient received only the liquid portion of Menveo 2 vial). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK receipt date: 23-Oct-2023 The reporter consented to follow-up. The patient received only the liquid portion of Menveo  2 vial, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.
Erythema, edema, pain and warmth of upper extremity from shoulder to elbow. Onset within 5-8 hours of vaccination.
Diarrhea; Fever of roughly 38.5C; Mild tiredness; Loss of appetite; Mild injections site tenderness; This is a spontaneous report received from a contactable consumer, the patient. A 20-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: ER8732) via an unspecified route of administrated on 26Mar2021 at 17:45 (at the age of 20-years-old) as a DOSE 1, SINGLE for COVID-19 immunisation. Medical history included COVID-19 from Dec2020 to unknown date. Concomitant medications were not reported. The patient had no known allergies to medications, food or other products. The patient did not received any other vaccines within 4 weeks prior to the vaccine. Prior to vaccination the patient was diagnosed with COVID-19. Since the vaccination the patient was not tested for COVID-19. On 27March2021 at 15:00 the patient experienced Fever of roughly 38.5C, mild tiredness, loss of appetite and mild injections site tenderness and at 15:45 after 22 hours of the first dose of vaccine, the patient experienced diarrhea. All foods consumed within the timeframe were unassociated with incidents of diarrhea in the past, though not frequently consumed. These included rye and mushroom soup, neither of which are associated with allergies or intolerances. The patient stated that this was not to say that there was a definitive connection with the first dose of the vaccine, but a correlation was present. The patient did not received any treatment for the reported events. The patient underwent lab tests or procedure, which include body temperature on 27Mar2021 and tested with a temperature of 38.5C. The clinical outcome of the events diarrhea, fever, mild tiredness, loss of appetite and mild injections site tenderness were recovering.   No follow-up attempts are needed. No further information expected.  Amendment: This follow-up report is being submitted to amend previously reported information: The date for Lab data captured as: 27Mar2021, Narrative 'The patient underwent lab tests or procedure, which include body temperature on an unknown date and tested with a temperature of 38.5C' update as 'The patient underwent lab tests or procedure, which include body temperature on 27Mar2021 and tested with a temperature of 38.5C' and Dose description was updated in narrative.
On the date reported, I began finding otherwise unexplainable bruising on my legs. Not long after, I began bruising on my wrists and fingers. In totality, I have acquired more than 10 bruises since receiving my second dose of the Pfizer vaccine.
Patient reported onset "rash"  on legs which spread to buttocks and arms.  Not painful and not itchy.  Seen 4/5/13- showed phone photos of diffuse confluent purplish-red rash.  PE showed remained non-blanching 3-4 mm dark red palpable papules on legs and arms.  No rash on palms or soles or mucuos membranes.
Didn't feel well by the 21st mid day and began having muscle pain in upper back, shoulders, neck and couldn't' cough w/out head pain. On the 22nd noticed welt and swelling at injection site that went from the back of my arm to underneath of arm. Painful to even put on deodorant. Saw doctor who was worried about treating an possibly adding possible side effects.
Patient up to date on COVID vaccines admitted with altered mental status and positive COVID PCR.  Provider d/c note:  "Brief Summary of Hospital Stay: (Include Significant Findings and Invasive Procedures) the patient presented confused found to be in HHS. Treated with insulin infusion and fluids with slow but complete resolution of AMS by day 2. He was found to have covid, had a fever x1, leukocytosis but improved without antibiotics. No bacterial infection suspected. He had expressive aphasia on 10/9 and was mute on 10/8 however this resolved. CT negative, could not get MRI due to baclofen pump tubing. Clinical stroke seems at the least possible."
Within 2 minutes of receiving FLUZONE, she became lightheaded and had near syncope. She was taken to room to lie down and within 10 minutes stated she was nauseated and had a headache. B/P was low at 102/60 which was within her normal range. She improved enough to be taken home within 1/2 hour. Around 6:00 a phone call to patient was made and she stated she was very tired but was feeling somewhat better. (This was on a Friday) Monday, the patient was again contacted and reported that she had woken up with sweats 3 x during the night and felt slightly disoriented. She felt better on 2/11/17 when she awoke but felt fatigued the whole day. She states that she is now feeling much better now (2/13/17) "just a little tired yet".
Joint inflammation the day after my second dose that led to ?throwing out? my back by bending over. My kids had to put my legs on the couch for me. This symptom improved, but the pain in my back is now returning. I?m concerned this will become a long term pattern. I will seek medical attention if it happens a third time or doesn?t improve in a few days.
Induration and redness/swelling in area where injection given. Warm to touch.Arm sore above and below area where injection given.
SWOLLEN LIPS AND TONGUE; SLURRED SPEECH; This spontaneous report received from a patient concerned a 67 year old female. The patient's weight was 140 pounds, and height was 67 inches. The patient's concurrent conditions included non-smoker, and non-alcohol user, and other pre-existing medical conditions included no abuse or illicit drug usage. The patient experienced anaphylactic reaction to morphine and drug allergy when treated with morphine, drug allergy when treated with codeine, lisinopril, hydrocodone bitartrate/paracetamol, and tramadol. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 206A21A, expiry: 07-AUG-2021) dose was not reported, administered on 12-JUL-2021 for prophylactic vaccination. No concomitant medications were reported. On JUL-2021, the subject experienced slurred speech. On 12-JUL-2021, the subject experienced swollen lips and tongue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from slurred speech on JUL-2021, and was recovering from swollen lips and tongue. This report was non-serious.
Headache, SkinRash & Rash  Narrative:  Had to go to the ER, started with a rash all over his body and itchiness, was given Prednisone and Benadryl, and today feels like he has a  headache. Also feels clammy. Meds given in ER helped the rash some, less reddened today.
Information has been received from a licensed practical nurse concerning now a 5 year old male with no past medical history and no allergies who on 01/28/1997 at 10am was vaccinated with a first dose of varicella vaccine SC in the thigh. There was no concomitant medication or illness at the time of vaccinations. On 09/05/2001 at 3pm, the pt had an outbreak of chicken pox. The pt had 65-70 raise fluid-filled vesicles mainly on his back and legs, and a few on his neck. There were no systemic symptoms. Subsequently, on 09/10/2001, the pt recovered from the chicken pox. Additional info has been requested.
Persistent headache - still occurring more than three weeks later.  Muscle relaxers, Tylenol PM, Aleve, Motrin, RX migraine meds do nothing to relieve the headache
within 24 hours, the patient developed diarrhea, fever, chills, dizziness, headaches, fatigue, muscle cramps, vomiting, aches, and pains throughout the entire body. Symptoms subsided after 48 hours after the shot was administered. Symptoms were most prevalent from 14-30 hours after initial vaccine.  Hot showers alleviated pain, and aided vomiting Bed rest when possible. Oral medication to relieve fevers/chills were ineffective due to vomiting.
This case was reported by a pharmacist via call center representative and described the occurrence of injection site itching in a 59-year-old female patient who received FLULAVAL QUADRIVALENT 2018-2019 season (batch number 59TS2, expiry date May 2019) for prophylaxis. On 5th October 2018, the patient received FLULAVAL QUADRIVALENT 2018-2019 season. On 5th October 2018, immediately after receiving FLULAVAL QUADRIVALENT 2018-2019 season, the patient experienced injection site itching, injection site erythema, injection site warmth, injection site pain and injection site swelling. On an unknown date, the outcome of the injection site itching, injection site erythema, injection site warmth, injection site pain and injection site swelling were recovering/resolving. It was unknown if the reporter considered the injection site itching, injection site erythema, injection site warmth, injection site pain and injection site swelling to be related to FLULAVAL QUADRIVALENT 2018-2019 season. Additional details were reported as follows: The patient revived FLULAVAL vaccine on the left deltoid. Shortly after vaccination, the patient experienced warmth, circular redness, puffiness and itching at around the injection site.
Erythema, swelling and pain at the injection site. Supportive care instructions given- no antibiotics required.
patient did not have an adverse reaction. Patient was supposed to have the immunizations separated since Kinrix is only for age 4-6 years
This spontaneous report as received from a pharmacist refers to a 67 year old female patient with DEMEROL allergy. On 19-NOV-2013 the patient was vaccinated with ZOSTAVAX (lot # J011212, expiration date 29-AUG-2014), 0.65 ml, subcutaneous in the left arm. The patient developed a rash on her left arm, at the injection site after receiving ZOSTAVAX on an unknown date in 2013. The patient came back in to the pharmacy on an unknown date to seek medical attention. No lab diagnostics studies were performed. The patient was using hydrocortisone (manufacturer unknown) cream on the rash. The patient was recovering from the event at the time of reporting. Additional information has been requested.
Dizzy, slighly sweaty. BPs 175/92 (pulse 61), 149/84 (pulse 59).